Sunshine Act Reporting: Clarification for Clinical Research 2018 is an event dedicated to the reporting requirements for lifesciences companies related to sunshine act with respect to clinical trial activities.
Sunshine Act Reporting: Clarification for Clinical Research 2018 covers topics such as:
- Templates for reporting format
- Tracking
- Exclusions
- Useful links
- Penalties
- Purpose of the Sunshine Act
- What is reported?
- Who is required to report under the Sunshine Act?
Sunshine Act Reporting: Clarification for Clinical Research 2018 intended for:
- Clinical trial Professionals such as project managers, CRAs, medical writers
- Manufacturers of FDA regulated products: Drug, Medical Device and Biotech Companies
- Regulatory Affairs Professionals
- Senior Management for companies developing new products for US market
- People investing in FDA-regulated products intended for the US market